Northleaf hires London MD
The Toronto-headquartered firm, which last year raised $1.3bn for secondaries, has appointed Sophia Damianou as MD of EMEA business development.

SECONDARIES INVESTOR
Register to unlock this content
Daily global secondaries market news and intelligence
Curated insights to keep you ahead of GP-led and LP-led secondaries
Faster, data-driven decision making powered by our AI interface, 'Ask PEI'
Access to proprietary research and reports
Selected fund performance and investor activity data






